ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................*JDIM360 Ver 2.15 (14 Jul 2008) - 2999001/0201111242175834CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120120822W184deBibliographieenBibliographyfrBibliographieEP08772467.02008070920100210enenen948855 P20070710US2012082220123420100421201016201102232011082010100120110223AT20110223BE20110523BG20110223CY20110223CZ20120201DE20110223DK20110223EE20110603ES20110223FI20110801FR20110524GR20110223IT20110223LT20110223LV20110223NL20110223PL20110623PT20110223RO20110223SE20110223SI20110223SK20120822201234A61K 9/08 20060101AFI20090204BHEP A61K 47/26 20060101ALI20090204BHEP A61K 38/26 20060101ALI20090204BHEP deGLP-1-FC FUSIONSPROTEIN-FORMULIERUNGenGLP-1-FC FUSION PROTEIN FORMULATIONfrFORMULATION DE PROTÉINE DE FUSION GLP-1-FCWO-A-2006/068910NG, Kingman10745 Putnam PlaceCarmel, Indiana 46032USELI LILLY AND COMPANY100116194X17652 EPLilly Corporate CenterIndianapolis, IN 46285USKent, Lindsey Ruthet al101136705Eli Lilly and Company Limited Lilly Research Center European Patent Operations Sunninghill RoadEarl Wood Manor Windlesham Surrey GU20 6PHGBATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMTNLNOPLPTROSESISKTRAL20100210BA20100210MK20100210RS20100210US200806947320080709enWO200900956220090115200903